‘Holy grail’ of gene therapy still a long way off for cystic fibrosis – Financial Times
Financial Times |
'Holy grail' of gene therapy still a long way off for cystic fibrosis
Financial Times Until six years ago, there was nothing that could stop the relentless march of cystic fibrosis, a relatively rare disease that affects roughly 75,000 people worldwide, which causes the build-up of thick mucus in the lungs, pancreas, and other organs … |
